News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
355,207 Results
Type
Article (16764)
Company Profile (47)
Press Release (338395)
Multimedia
Podcasts (20)
Webinars (6)
Section
Business (110607)
Career Advice (953)
Deals (20334)
Drug Delivery (41)
Drug Development (40163)
Employer Resources (82)
FDA (7209)
Job Trends (6842)
News (179443)
Policy (13605)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1257)
Academic (1)
Accelerated approval (11)
Adcomms (12)
Allergies (60)
Alliances (24196)
ALS (79)
Alzheimer's disease (703)
Antibody-drug conjugate (ADC) (90)
Approvals (7411)
Artificial intelligence (178)
Autoimmune disease (55)
Automation (11)
Bankruptcy (147)
Best Places to Work (5330)
BIOSECURE Act (6)
Biosimilars (82)
Biotechnology (31)
Bladder cancer (68)
Brain cancer (21)
Breast cancer (247)
Cancer (1884)
Cardiovascular disease (187)
Career advice (818)
Career pathing (17)
CAR-T (106)
CDC (22)
Celiac Disease (1)
Cell therapy (287)
Cervical cancer (15)
Clinical research (35234)
Collaboration (627)
Company closure (1)
Compensation (405)
Complete response letters (15)
COVID-19 (1321)
CRISPR (30)
C-suite (440)
Cystic fibrosis (47)
Data (2916)
Denatured (10)
Depression (53)
Diabetes (233)
Diagnostics (3359)
Digital health (13)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (79)
Drug pricing (67)
Drug shortages (19)
Duchenne muscular dystrophy (96)
Earnings (49689)
Editorial (26)
Employer branding (10)
Employer resources (78)
Events (54553)
Executive appointments (549)
FDA (8597)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (628)
Gene editing (57)
Generative AI (16)
Gene therapy (243)
GLP-1 (431)
Government (1546)
Grass and pollen (3)
Guidances (247)
Healthcare (9160)
HIV (36)
Huntington's disease (17)
IgA nephropathy (26)
Immunology and inflammation (95)
Immuno-oncology (19)
Indications (37)
Infectious disease (1425)
Inflammatory bowel disease (88)
Inflation Reduction Act (7)
Influenza (40)
Intellectual property (55)
Interviews (143)
IPO (9621)
IRA (24)
Job creations (1675)
Job search strategy (714)
JPM (16)
Kidney cancer (13)
Labor market (30)
Layoffs (190)
Leadership (20)
Legal (3469)
Liver cancer (43)
Longevity (4)
Lung cancer (210)
Lymphoma (165)
Machine learning (10)
Management (29)
Manufacturing (274)
MASH (91)
Medical device (6242)
Medtech (6267)
Mergers & acquisitions (11277)
Metabolic disorders (557)
Multiple sclerosis (87)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (26)
Neuroscience (1250)
NextGen: Class of 2026 (3149)
Non-profit (2088)
Now hiring (9)
Obesity (232)
Opinion (85)
Ovarian cancer (64)
Pain (74)
Pancreatic cancer (75)
Parkinson's disease (125)
Partnered (14)
Patents (85)
Patient recruitment (178)
Peanut (21)
People (35050)
Pharmaceutical (13)
Pharmacy benefit managers (12)
Phase 1 (9189)
Phase 2 (15246)
Phase 3 (13303)
Pipeline (2761)
Policy (110)
Postmarket research (1461)
Preclinical (3527)
Press Release (67)
Prostate cancer (109)
Psychedelics (18)
Radiopharmaceuticals (140)
Rare diseases (362)
Real estate (2881)
Recruiting (26)
Regulatory (10399)
Reports (27)
Research institute (1109)
Resumes & cover letters (135)
Rett syndrome (20)
RNA editing (2)
RSV (28)
Schizophrenia (80)
Series A (114)
Series B (88)
Service/supplier (2)
Sickle cell disease (32)
Special edition (4)
Spinal muscular atrophy (85)
Sponsored (14)
Startups (1838)
Stomach cancer (5)
Supply chain (31)
Tariffs (20)
The Weekly (10)
Vaccines (435)
Venture capital (27)
Weight loss (146)
Women's health (28)
Worklife (8)
Date
Last 7 days (249)
Last 30 days (882)
Last 365 days (13894)
2026 (1205)
2025 (14241)
2024 (16828)
2023 (19730)
2022 (26883)
2021 (29260)
2020 (27613)
2019 (22963)
2018 (17537)
2017 (16657)
2016 (15808)
2015 (19572)
2014 (14657)
2013 (11771)
2012 (12602)
2011 (13407)
2010 (12506)
Location
Africa (385)
Alabama (24)
Alaska (4)
Arizona (124)
Arkansas (3)
Asia (20710)
Australia (3487)
California (5135)
Canada (1504)
China (450)
Colorado (186)
Connecticut (220)
Delaware (144)
Europe (49938)
Florida (773)
Georgia (158)
Idaho (39)
Illinois (355)
India (30)
Indiana (205)
Iowa (12)
Japan (259)
Kansas (67)
Kentucky (24)
Louisiana (15)
Maine (62)
Maryland (577)
Massachusetts (3800)
Michigan (141)
Minnesota (289)
Mississippi (1)
Missouri (56)
Montana (18)
Nebraska (17)
Nevada (69)
New Hampshire (22)
New Jersey (1509)
New Mexico (12)
New York (1339)
North Carolina (646)
North Dakota (4)
Northern California (2583)
Ohio (168)
Oklahoma (7)
Oregon (9)
Pennsylvania (959)
Puerto Rico (5)
Rhode Island (20)
South America (573)
South Carolina (24)
Southern California (1981)
Tennessee (84)
Texas (695)
United States (18172)
Utah (146)
Virginia (116)
Washington D.C. (24)
Washington State (448)
West Virginia (2)
Wisconsin (67)
Wyoming (2)
355,207 Results for "sosei group corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office
Sosei Group Corporation, announces that at a meeting held on 15 February 2024, its Board of Directors resolved to change the corporate names of the Company and its subsidiaries and the location of the head office of the Company.
February 15, 2024
·
6 min read
Business
Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer
Sosei Group Corporation announces the appointment of Mr. Toshihiro Maeda as Chief Operating Officer.
January 5, 2024
·
4 min read
Press Releases
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 24, 2025
·
4 min read
Layoffs
Nxera’s Quest for Profitability Claims 15% of Workforce
Nxera, which formerly went by Sosei, will also reprioritize its pipeline to focus on obesity, metabolic and endocrine diseases.
November 18, 2025
·
2 min read
·
Tristan Manalac
Policy
Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea
Sosei Group Corporation announces that PIVLAZ™ 150 mg has received marketing approval from the Ministry of Food and Drug Safety in South Korea for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage securing.
December 7, 2023
·
8 min read
Business
Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of schizophrenia
Boehringer Ingelheim and Sosei Group Corporation announced they have entered a global collaboration and exclusive option-to-license agreement.
March 11, 2024
·
10 min read
Genetown
Sosei Heptares Webinar Presentation for FY2023 Financial Results
Sosei Group Corporation will announce its earnings results and present operational highlights for the 12 months ended 31 December 2023 on Tuesday, 13 February 2024.
January 22, 2024
·
2 min read
Genetown
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2023
Sosei Group Corporation provides an update on operational activities and reports its consolidated results for the 12 months ended 31 December 2023.
February 13, 2024
·
10 min read
Business
Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma
Sosei Group Corporation announces that the re-election of its Board of Directors and Executive Officers was approved at the Company’s 34th Annual Shareholders’ Meeting and a subsequent Board of Directors meeting, held in Tokyo.
March 27, 2024
·
4 min read
Press Releases
Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update
December 15, 2025
·
8 min read
1 of 35,521
Next
